These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 15187531)
1. The cost-effectiveness of proton pump inhibitors for bleeding peptic ulcers: The unanswered questions. Devlin JW; Welage LS Crit Care Med; 2004 Jun; 32(6):1415-6. PubMed ID: 15187531 [No Abstract] [Full Text] [Related]
2. High-dose intravenous proton pump inhibition following endoscopic therapy in the acute management of patients with bleeding peptic ulcers in the USA and Canada: a cost-effectiveness analysis. Barkun AN; Herba K; Adam V; Kennedy W; Fallone CA; Bardou M Aliment Pharmacol Ther; 2004 Mar; 19(5):591-600. PubMed ID: 14987328 [TBL] [Abstract][Full Text] [Related]
3. Editorial: Intravenous Proton Pump Inhibitors for Bleeding Peptic Ulcer: What is the Most Cost-Effective Approach? Peterson K; Bjorkman DJ Am J Gastroenterol; 2016 Oct; 111(10):1399-1401. PubMed ID: 27694876 [TBL] [Abstract][Full Text] [Related]
4. Are higher doses of proton pump inhibitors better in acute peptic bleeding? Villalón A; Olmos R; Rada G Medwave; 2016 Jun; 16 Suppl 2():e6476. PubMed ID: 27390875 [TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness of proton pump inhibitor therapy for acute peptic ulcer-related bleeding. Erstad BL Crit Care Med; 2004 Jun; 32(6):1277-83. PubMed ID: 15187506 [TBL] [Abstract][Full Text] [Related]
7. Proton pump inhibitors after endoscopy in peptic ulcer bleeding. Lin HJ Am J Gastroenterol; 2009 Jun; 104(6):1595; author reply 1595-6. PubMed ID: 19491877 [No Abstract] [Full Text] [Related]
8. High or low doses of PPIs for patients with peptic ulcer bleeding? Lin HJ Arch Intern Med; 2010 Oct; 170(18):1699-700; author reply 1700. PubMed ID: 20937935 [No Abstract] [Full Text] [Related]
9. Review: in high-risk ulcers, intermittent and continuous PPI therapy do not differ for recurrent bleeding. Long M; Lichtenstein D Ann Intern Med; 2015 Jan; 162(2):JC8. PubMed ID: 25599368 [No Abstract] [Full Text] [Related]
10. Outcomes of peptic ulcer bleeding following treatment with proton pump inhibitors in routine clinical practice: 935 patients with high- or low-risk stigmata. Lanas A; Carrera-Lasfuentes P; García-Rodríguez LA; García S; Arroyo-Villarino MT; Ponce J; Bujanda L; Calleja JL; Polo-Tomas M; Calvet X; Feu F; Perez-Aisa A Scand J Gastroenterol; 2014 Oct; 49(10):1181-90. PubMed ID: 25144754 [TBL] [Abstract][Full Text] [Related]
12. Cost implications of administering intravenous proton pump inhibitors to all patients presenting to the emergency department with peptic ulcer bleeding. Gagnon YM; Levy AR; Eloubeidi MA; Arguedas MR; Rioux KP; Enns RA Value Health; 2003; 6(4):457-65. PubMed ID: 12859587 [TBL] [Abstract][Full Text] [Related]
13. Intermittent bolus or continuous infusion of proton pump inhibitors for ulcer bleeding? Hsu YC; Lin HJ JAMA Intern Med; 2015 Mar; 175(3):461. PubMed ID: 25730565 [No Abstract] [Full Text] [Related]
19. Hypoalbuminemia is a predictor of mortality and rebleeding in peptic ulcer bleeding under proton pump inhibitor use. Cheng HC; Yang EH; Wu CT; Wang WL; Chen PJ; Lin MY; Sheu BS J Formos Med Assoc; 2018 Apr; 117(4):316-325. PubMed ID: 28751088 [TBL] [Abstract][Full Text] [Related]
20. Intragastric pH with oral versus intravenous bolus plus infusion proton pump inhibitor therapy in patients with bleeding ulcers. Lin HJ; Tsai JJ Gastroenterology; 2008 Nov; 135(5):1804-5. PubMed ID: 18840442 [No Abstract] [Full Text] [Related] [Next] [New Search]